30 May 2022 3 Min Read
Medicines regulator advises against using ivermectin for Covid-19
Sahpra’s decision based on a lack of evidence of the efficacy and safety of the drug
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In